 |
PDBsum entry 1myo
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
6:619-626
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
The structural basis of ankyrin-like repeat function as revealed by the solution structure of myotrophin.
|
|
Y.Yang,
S.Nanduri,
S.Sen,
J.Qin.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: Myotrophin is a 12.5 kDa protein that appears to have a key role in
the initiation of cardiac hypertrophy, a central process in many heart diseases.
Myotrophin primarily comprises ankyrin-like (ANK) repeats, the 33 amino acid
motifs involved in a wide range of protein-protein interactions. As a first step
in the structure-based search for cardiac hypertrophy antagonists and in order
to gain insight into the molecular basis of action of the ubiquitous and
multifunctional ANK repeat motif, we have determined the solution structure of
myotrophin using multidimensional heteronuclear NMR spectroscopy. RESULTS: The
myotrophin structure determination was based on 2786 experimental NMR
restraints, and the precision of the coordinates for the final 45
simulated-annealing structures is 0.43 A for the backbone atoms and 0.87 A for
all atoms. The structure of myotrophin is well defined and is ellipsoidal:
approximately 46 A long and 21 A wide. The ANK repeats, which constitute the
main part of the myotrophin structure, are characteristic of a hairpin-like
protruding tip followed by a helix-turn-helix motif. The V-shaped
helix-turn-helix of the ANK repeats stack sequentially in bundles and are
stabilized by compact hydrophobic cores, whereas the protruding tips are less
ordered. This arrangement is quite different to the continuous beta-sheet
topology observed in the corresponding regions of another ANK protein, 53BP2,
the structure of which was determined in complex with p53. CONCLUSIONS: The
solution structure of myotrophin provides important insights into the structural
and dynamic features of the ANK motif, and suggests that the protruding tips
with highly variable sequences may be critical to facilitate diverse
protein-protein recognition. The present structure also provides a molecular
basis for the further functional characterization of myotrophin and the
development of therapeutics for hypertrophy-related heart diseases.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 5.
Figure 5. The overall fold of myotrophin and comparisons
with 53BP2. (a) Ribbon representation of the myotrophin
structure. All helices are labeled sequentially (a1, a2, a3, a4,
a5, a6, a7 and a8). The structure is primarily composed of four
sequential helix-turn-helix motifs stacked as helix bundles. It
is clear that all the helices lie on one side of the protein,
whereas the loops including those from the ANK repeats protrude
to the other side of the protein, and are likely to be involved
in protein recognition. (b) Structural comparisons of the ANK
repeats of myotrophin and 53BP2. The superposition of ANK 1
(green) and ANK 2 of myotrophin (blue) onto ANK 2 (purple) and
ANK 3 (purple) of 53BP2, respectively. Although the fold of each
repeat is similar to those of 53BP2, the protruding tips from
the two repeats of myotrophin do not interact with each other
and are less well ordered. This is in contrast to the continuous
b sheet formed by the corresponding regions in 53BP2 complexed
with p53 [11]. The dynamics of the ANK repeats in myotrophin
were found to be different from those of 53BP2 [10]. The
protruding tips with highly variable sequences may be critical
in controlling diverse functions of various ANK repeat-bearing
proteins. (The figures were prepared with the program MOLSCRIPT
[25].)
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(1998,
6,
619-626)
copyright 1998.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.Takeda,
S.Minakata,
R.Koike,
I.Kawahata,
A.Narita,
M.Kitazawa,
M.Ota,
T.Yamakuni,
Y.Maéda,
and
Y.Nitanai
(2010).
Two distinct mechanisms for actin capping protein regulation--steric and allosteric inhibition.
|
| |
PLoS Biol,
8,
e1000416.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.F.Cervantes,
P.R.Markwick,
S.C.Sue,
J.A.McCammon,
H.J.Dyson,
and
E.A.Komives
(2009).
Functional dynamics of the folded ankyrin repeats of I kappa B alpha revealed by nuclear magnetic resonance.
|
| |
Biochemistry,
48,
8023-8031.
|
 |
|
|
|
|
 |
B.Das,
S.Gupta,
A.Vasanji,
Z.Xu,
S.Misra,
and
S.Sen
(2008).
Nuclear Co-translocation of Myotrophin and p65 Stimulates Myocyte Growth: REGULATION BY MYOTROPHIN HAIRPIN LOOPS.
|
| |
J Biol Chem,
283,
27947-27956.
|
 |
|
|
|
|
 |
D.U.Ferreiro,
C.F.Cervantes,
S.M.Truhlar,
S.S.Cho,
P.G.Wolynes,
and
E.A.Komives
(2007).
Stabilizing IkappaBalpha by "consensus" design.
|
| |
J Mol Biol,
365,
1201-1216.
|
 |
|
|
|
|
 |
N.Bhattacharya,
S.Ghosh,
D.Sept,
and
J.A.Cooper
(2006).
Binding of myotrophin/V-1 to actin-capping protein: implications for how capping protein binds to the filament barbed end.
|
| |
J Biol Chem,
281,
31021-31030.
|
 |
|
|
|
|
 |
C.Yang,
M.Pring,
M.A.Wear,
M.Huang,
J.A.Cooper,
T.M.Svitkina,
and
S.H.Zigmond
(2005).
Mammalian CARMIL inhibits actin filament capping by capping protein.
|
| |
Dev Cell,
9,
209-221.
|
 |
|
|
|
|
 |
M.Huang,
M.Pring,
C.Yang,
M.Taoka,
and
S.H.Zigmond
(2005).
Presence of a novel inhibitor of capping protein in neutrophil extract.
|
| |
Cell Motil Cytoskeleton,
62,
232-243.
|
 |
|
|
|
|
 |
C.H.Croy,
S.Bergqvist,
T.Huxford,
G.Ghosh,
and
E.A.Komives
(2004).
Biophysical characterization of the free IkappaBalpha ankyrin repeat domain in solution.
|
| |
Protein Sci,
13,
1767-1777.
|
 |
|
|
|
|
 |
A.Kohl,
H.K.Binz,
P.Forrer,
M.T.Stumpp,
A.Plückthun,
and
M.G.Grütter
(2003).
Designed to be stable: crystal structure of a consensus ankyrin repeat protein.
|
| |
Proc Natl Acad Sci U S A,
100,
1700-1705.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.S.Tang,
A.R.Fersht,
and
L.S.Itzhaki
(2003).
Sequential unfolding of ankyrin repeats in tumor suppressor p16.
|
| |
Structure,
11,
67-73.
|
 |
|
|
|
|
 |
M.Taoka,
T.Ichimura,
A.Wakamiya-Tsuruta,
Y.Kubota,
T.Araki,
T.Obinata,
and
T.Isobe
(2003).
V-1, a protein expressed transiently during murine cerebellar development, regulates actin polymerization via interaction with capping protein.
|
| |
J Biol Chem,
278,
5864-5870.
|
 |
|
|
|
|
 |
S.Malek,
D.B.Huang,
T.Huxford,
S.Ghosh,
and
G.Ghosh
(2003).
X-ray crystal structure of an IkappaBbeta x NF-kappaB p65 homodimer complex.
|
| |
J Biol Chem,
278,
23094-23100.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Knuefermann,
P.Chen,
A.Misra,
S.P.Shi,
M.Abdellatif,
and
N.Sivasubramanian
(2002).
Myotrophin/V-1, a protein up-regulated in the failing human heart and in postnatal cerebellum, converts NFkappa B p50-p65 heterodimers to p50-p50 and p65-p65 homodimers.
|
| |
J Biol Chem,
277,
23888-23897.
|
 |
|
|
|
|
 |
P.Michaely,
D.R.Tomchick,
M.Machius,
and
R.G.Anderson
(2002).
Crystal structure of a 12 ANK repeat stack from human ankyrinR.
|
| |
EMBO J,
21,
6387-6396.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.G.Sedgwick,
and
S.J.Smerdon
(1999).
The ankyrin repeat: a diversity of interactions on a common structural framework.
|
| |
Trends Biochem Sci,
24,
311-316.
|
 |
|
|
|
|
 |
R.Baumgartner,
C.Fernandez-Catalan,
A.Winoto,
R.Huber,
R.A.Engh,
and
T.A.Holak
(1998).
Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a.
|
| |
Structure,
6,
1279-1290.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |